Chemical Compound

6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,S*-(E))-(+/-)-

CAS Registry Number 93957-55-2
返回搜索 申请报价
6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,S*-(E))-(+/-)- 结构式
Primary record

6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,S*-(E))-(+/-)-

库存
864 克
纯度
98.9 %
CAS
93957-55-2

化合物标识与属性

CAS
93957-55-2
PubChem CID
23679527
SMILES
CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+]
Canonical SMILES
CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]

名称与同义词

  • FLUVASTATIN SODIUM
  • Fractal
  • Lescol
  • Vastin
  • Canef
  • Fluindostatin
  • Lipaxan
  • Lymetel
  • Locol
  • Primesin
  • Fluvastatin sodium salt
  • Cranoc
  • Almastatin
  • Primexin
  • Lochol
  • Lescol XL
  • fluvastatin
  • 93957-55-2
  • Pinmactil
  • Fluindostatin;
  • Fluvastatin Sanabo
  • Stefluvin xl
  • Luvinsta xl
  • Nandovar xl
  • Dorisin xl
  • Primesin;
  • Fractal;
  • Lipaxan;
  • Lymetel;
  • Cranoc;
  • Lescol;
  • Canef;
  • Locol;
  • (?)-Fluvastatin
  • Lescol (TN)
  • PYF7O1FV7F
  • (3S,5R)-fluvastatin sodium
  • Fluvastatin Sodium ER
  • UNII-PYF7O1FV7F
  • Ir(ppy)3;
  • (-)-3s,5r-fluvastatin sodium salt
  • (-)-fluvastatin sodium
  • RefChem:56569
  • Fluvastatin sodium [USAN]
  • (3S,5R)-FLUVASTATIN SODIUM SALT
  • Fluvastatin sodium hydrate
  • 94061-81-1
  • BDS32J3EZK
  • C24H25FNNaO4
  • Fluvastatin sodium salt hydrate
  • CCRIS 6848
  • C24H26FNO4.Na
  • Fluvastatin sodium [USAN:USP]
  • MFCD00929076
  • SCHEMBL41663
  • DTXSID3044758
  • (3S,5R)-Fluvastatin (sodium)
  • MLS002154037
  • ARD193813Na
  • Fluvastatin sodium (JAN/USP)
  • 3S,5R-Fluvastatin sodium salt
  • CHEBI:5137
  • CHEMBL241778
  • DTXCID5065306
  • FLUVASTATIN SODIUM [JAN]
  • CHEBI:77603
  • Fluvastatin sodium, (3S,5R)-
  • XU 62-320
  • sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate
  • C24-H26-F-N-O4.Na
  • FLUVASTATIN SODIUM [VANDF]
  • GLXC-08139
  • HMS2097L19
  • HMS3067L20
  • HMS3714L19
  • (3S,5R) Fluvastatin Sodium Salt
  • FLUVASTATIN SODIUM [MART.]
  • (-)-(3S,5R)-fluvastatin sodium
  • (3S,5R)-(-)-fluvastatin sodium
  • EBD33359
  • FLUVASTATIN SODIUM [USP-RS]
  • FLUVASTATIN SODIUM [WHO-DD]
  • FLUVASTATIN SODIUM SALT [MI]
  • HY-14664C
  • MFCD08063391
  • AKOS015894901
  • ACN-048183
  • CCG-220859
  • CID5281101
  • EBC-110059
  • XU-62-320
  • XU62320
  • FLUVASTATIN SODIUM [ORANGE BOOK]
  • FLUVASTATIN SODIUM [EP MONOGRAPH]
  • FLUVASTATIN SODIUM [USP IMPURITY]
  • FLUVASTATIN SODIUM [USP MONOGRAPH]
  • SC-26268
  • SMR000705060
  • XU 62 320
  • (3S,5R)-XU 62-320
  • CS-0019898
  • F0820
  • D00892
  • A844750
  • A917249
  • I06-043
  • Q27147205
  • sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate
  • Fluvastatin sodium, European Pharmacopoeia (EP) Reference Standard
  • (3s,5r)-7-(3-(4-fluorophenyl)-1-isopropyl-1h-indol-2-yl)-3,5-dihydroxyhept-6-enoic acidsodium salt
  • 155229-76-8
  • 93957-58-5
  • Fluvastatin sodium, United States Pharmacopeia (USP) Reference Standard
  • rel-(3S,5R,E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt
  • Rel-Sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate
  • Sodium (+-)-(3R*,5S*,6E)-7-(3-(p-fluorophenyl)-1-isopropylindol-2-yl)-3,5-dihydroxy-6-heptenoate
  • Fluvastatin for system suitability, European Pharmacopoeia (EP) Reference Standard
  • Fluvastatin sodium, Pharmaceutical Secondary Standard; Certified Reference Material
  • (+/-)-(3R*,5S*,6E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt
  • (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt
  • (3S,5R)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt
  • (3S,5R)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
  • (3S,5R)-rel-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt
  • 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, monosodium salt, (R*,S*-(E))-(+-)-
  • 6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,S*-(E))-(+/-)-
  • 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, monosodium salt, (3S,5R,6E)-
  • 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, monosodium salt, [R-[R*,S*-(E)]]-
  • 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, sodium salt (1:1), (3S,5R,6E)-
  • SODIUM (+/-)-(3R*,5S*,6E)-7-(3-(P-FLUOROPHENYL)-1-ISOPROPYLINDOL-2-YL)-3,5-DIHYDROXY-6-HEPTENOATE
  • Sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
  • sodium (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
  • sodium (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
  • sodium (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate
  • sodium, (e)-(3s,5r)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1h-indol-2-yl]-3,5-dihydroxy-hept-6-enoate
  • sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate